ZERLA, DANIELE SERGIO
ZERLA, DANIELE SERGIO
Dipartimento di Scienze Farmaceutiche
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction
2012 G. Facchetti, E. Cesarotti, M. Pellizzoni, D. Zerla, I. Rimoldi
3-(Hydroxy(phenyl)methyl)azetidin-2-ones obtained via catalytic asymmetric hydrogenation or by biotransformation
2011 I. Rimoldi, E. Cesarotti, D. Zerla, F. Molinari, D. Albanese, C. Castellano, R. Gandolfi
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH)
2014 G. Facchetti, D. Zerla, M. Fusè, M. Pellizzoni, C. Castellano, E. Cesarotti, R. Gandolfi, I. Rimoldi
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH)
2014 D. Zerla, G. Facchetti, M. Fusè, M. Pellizzoni, C. Castellano, E. Cesarotti, R. Gandolfi, I. Rimoldi
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer
2012 M. Pellizzoni, G. Facchetti, E. Cesarotti, I. Rimoldi, D. Zerla
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer
2010 E. Cesarotti, I. Rimoldi, D.S. Zerla
Asymmetric Hydrogenation of prochiral Ketones catalyzed by Ru(II)Cl2diphosphine/diamine system
2008 P. Spalluto, E. Cesarotti, I. Rimoldi, D. Zerla
Asymmetric reduction by transition metals complexes and biocatalysts
2010 I. Rimoldi, E. Cesarotti, F.E. Molinari, D. Romano, D.S. Zerla, R. Gandolfi
catalisi enantioselettiva : sintesi di istidina non naturale e istidina non naturale deuterata
2006 E. Cesarotti, I. Rimoldi, P. Spalluto, D. Zerla
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction
2011 I. Rimoldi, M. Pellizzoni, G. Facchetti, F.E. Molinari, D.S. Zerla, R. Gandolfi
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin
2013 N. Ferri, S. Cazzaniga, L. Mazzarella, G. Curigliano, G. Lucchini, D. Zerla, R. Gandolfi, G. Facchetti, M. Pellizzoni, I. Rimoldi
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre
2014 D.S. Zerla, I. Rimoldi, E. Cesarotti, G. Facchetti, M. Pellizzoni, M. Fusè
difosfine chelanti innovative e loro applicazioni in catalisi asimmetrica.
2006 E. Cesarotti, I. Rimoldi, P. Spalluto, D. Zerla
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes
2012 I. Rimoldi, G. Facchetti, E. Cesarotti, M. Pellizzoni, M. Fusè, D.S. Zerla
Histidine and deuterium labelled histidine by asymmetric catalytic reduction
2007 D. Zerla, E. Cesarotti
Histidine and deuterium labelled histidine by asymmetric catalytic reduction with gaseous H-2 or D-2 : the role of strong non-coordinating acids
2008 E. Cesarotti, I. Rimoldi, D. Zerla, G. Aldini
Histidine and deuterium-labelled histidine by asymmetric catalytic reduction and assignment of the absolute stereochemistry by neutron diffraction
2010 A. Albinati, E. Cesarotti, S.A. Mason, I. Rimoldi, S. Rizzato, D.S. Zerla
Hystidine and deuterium labelled hystidine by catalytic reduction with Rh(I)-diphosphine complexes and non coordinating strong acids.
2008 E. Cesarotti, I. Rimoldi, D. Zerla
Natural and unnatural aminoacids by catalytic reduction with Rh(I)-diphosphine complexes; role of strong acids in the synthesis of deuterium labelled histidine.
2008 D. Zerla, E. Cesarotti
Natural, unnatural and D2 labelled aminoacids by asymmetric hydrogenation
2007 E. Cesarotti, I. Rimoldi, D. Zerla